Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
April 04, 2024 08:11 ET
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
January 23, 2024 08:00 ET
|
Biognosys AG
Biognosys' new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US biopharma customers.
(un)Common Logic Introduces Conversion Optimization Rate Calculator
January 18, 2024 09:00 ET
|
(un)Common Logic
Austin, Texas, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Austin-based digital marketing agency (un)Common Logic has announced a new tool for determining the potential revenue increase from optimizing a...
Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023
July 24, 2023 16:35 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Contract Research Organization Services Market Size to Surpass USD 188.52 Billion by 2030, exhibiting a CAGR of 12.5%
June 19, 2023 08:06 ET
|
Fortune Business Insights
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global Contract Research Organization Services Market size was valued at USD 73.38 billion in 2022 and is...
Inotiv, Inc. to Participate in May Investor Conferences
May 19, 2023 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 19, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
May 17, 2023 08:12 ET
|
Be The Match
MINNEAPOLIS, May 17, 2023 (GLOBE NEWSWIRE) -- The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving...
Inotiv, Inc. Announces Second Quarter Fiscal 2023 Financial Results
May 11, 2023 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 11, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Expands Safety Pharmacology Offering to Include Cardiopulmonary Telemetry
May 04, 2023 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development...
Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023
April 26, 2023 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...